TNXP
Tonix Pharmaceuticals Holding Corp.
NASDAQHealthcareBiotechnologyUS
Rating:B-
Company Profile
CEO
Seth Lederman
IPO Date
2012-05-10
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Tonix Pharmaceuticals Holding Corp.
CEO
Seth Lederman
IPO Date
2012-05-10
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 5,000 |
| $11.65 |
| 9 Jun 2026 | LEDERMAN SETH | director, officer: Chief Executive Officer | P-Purchase | Acquired | 5,000 | $11.79 |
| 14 May 2026 | Stillwell Richard Newcomb | director | A-Award | Acquired | 22,700 | $13.28 |
| 14 May 2026 | OLUKOTUN ADEOYE Y | director | A-Award | Acquired | 22,700 | $13.28 |
| 14 May 2026 | Bell Margaret Smith | director | A-Award | Acquired | 22,700 | $13.28 |
| 14 May 2026 | Hunter James Randolph Jr | director | A-Award | Acquired | 22,700 | $13.28 |
| 14 May 2026 | Treco James | director | A-Award | Acquired | 22,700 | $13.28 |
| 14 May 2026 | GRANGE DAVID L | director | A-Award | Acquired | 22,700 | $13.28 |
| 14 May 2026 | BAGGER RICHARD H | director | A-Award | Acquired | 22,700 | $13.28 |